The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holman, P. O.
Right arrow Articles by Jameson, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holman, P. O.
Right arrow Articles by Jameson, S. C.
The Journal of Immunology, 2005, 174: 3986-3991.
Copyright © 2005 by The American Association of Immunologists

Characterizing the Impact of CD8 Antibodies on Class I MHC Multimer Binding1

Philmore O. Holman, Elizabeth R. Walsh and Stephen C. Jameson2

Center for Immunology and Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455

Many studies have suggested that CD8 Abs affect the binding of class I MHC tetramers/multimers to CD8+ T cells, which has led to the interpretation that CD8 participates directly in multimer binding. In contrast, a recent publication has argued that CD8 Abs instead cause reorganization of TCR distribution and hence have an indirect effect on multimer binding to the TCR alone. We address these issues by testing the role of CD8 and the impact of CD8 Abs on the binding of normal and mutant multimers to Ag-specific mouse T cells. Our data suggest that, in this system, CD8 Abs act directly on CD8 and only mediate their effects on multimer binding when CD8 is capable of binding to the multimer. These data reinforce the paradigm that CD8 plays an active and direct role in binding of class I MHC multimers.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
L. L. Jones, S. E. Brophy, A. J. Bankovich, L. A. Colf, N. A. Hanick, K. C. Garcia, and D. M. Kranz
Engineering and Characterization of a Stabilized {alpha}1/{alpha}2 Module of the Class I Major Histocompatibility Complex Product Ld
J. Biol. Chem., September 1, 2006; 281(35): 25734 - 25744.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
B. Neveu, K. Echasserieau, T. Hill, K. Kuus-Reichel, E. Houssaint, M. Bonneville, and X. Saulquin
Impact of CD8-MHC class I interaction in detection and sorting efficiencies of antigen-specific T cells using MHC class I/peptide multimers: contribution of pMHC valency
Int. Immunol., July 1, 2006; 18(7): 1139 - 1145.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Kao, M. M. Sandau, M. A. Daniels, and S. C. Jameson
The Sialyltransferase ST3Gal-I Is Not Required for Regulation of CD8-Class I MHC Binding during T Cell Development.
J. Immunol., June 15, 2006; 176(12): 7421 - 7430.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
C. Kao, M. A. Daniels, and S. C. Jameson
Loss of CD8 and TCR binding to Class I MHC ligands following T cell activation
Int. Immunol., December 1, 2005; 17(12): 1607 - 1617.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.